News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

This week the University of Liverpool launched the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), an initiative to improve early detection of rare eye cancers.

Cancer Research Horizons, the innovation arm of Cancer Research UK, has announced a collaboration with Histofy, a leader in AI-driven histopathology solutions, to develop tools that predict ...

Source BioScience acquires Cambridge Clinical Laboratories

As debate over changes to Britain’s welfare system continues to dominate the news, members of a multidisciplinary team of researchers are beginning a two-year study to examine the case for...

Citylabs 4.0, the newest phase of Manchester’s world-leading health innovation campus, has officially opened its doors, further strengthening the city’s reputation as a major centre for ...

Cancer Research Horizons launches the Cancer Impact Club, a community of business builders whose philanthropy, expertise and networks will help shape the future of cancer treatment.

Universities are well aware of the strategic importance of commercialising innovation and a recent report shows that four UK universities are in the top ten in Europe for numbers of startups...

The University of Manchester is a global leader in life sciences with cutting-edge research, advanced technology, and world-class facilities. Key areas include genomics, neuroscience, cancer...

Key takeaways and how Morula Health is making a difference

Dr Catherine Headley highlights how The University of Manchester Innovation Factory transforms research into real-world impact, driving progress through spinouts, collaborations, and investm...

We are currently looking for industrial co-applicants to collaborate on the innovative and rapidly evolving field of phage therapeutics (see below for details) and the lead applicant is Dr W...

Cancer Research UK, Cytovation and the Norwegian Cancer Society have signed an agreement to bring Cytovation’s lead asset, CY-101, into a multi-national Phase 2 clinical trial for patients...

Search Site

Sign up to our Newsletter

Our Valued Sponsors & Partners